A61K 31/36
Compounds containing methylenedioxyphenyl groups
Official title: Compounds containing methylenedioxyphenyl groups, e.g. sesamin
A61K31/36 (Compounds containing methylenedioxyphenyl groups) appears on 503 US grants and 880 published applications in this corpus.
Search patents in A61K- Granted patents
- 503
- Published applications
- 880
- Assignees
- 457
- Inventors
- 1,971
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 2 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 3 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 3 | 0 |
| 1987 | 2 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 3 | 0 |
| 1993 | 5 | 0 |
| 1994 | 2 | 0 |
| 1995 | 4 | 0 |
| 1996 | 5 | 0 |
| 1997 | 8 | 0 |
| 1998 | 8 | 0 |
| 1999 | 11 | 0 |
| 2000 | 8 | 0 |
| 2001 | 8 | 4 |
| 2002 | 11 | 11 |
| 2003 | 6 | 19 |
| 2004 | 7 | 26 |
| 2005 | 5 | 9 |
| 2006 | 10 | 25 |
| 2007 | 1 | 15 |
| 2008 | 4 | 12 |
| 2009 | 9 | 22 |
| 2010 | 11 | 32 |
| 2011 | 5 | 14 |
| 2012 | 6 | 21 |
| 2013 | 12 | 33 |
| 2014 | 21 | 33 |
| 2015 | 19 | 38 |
| 2016 | 20 | 36 |
| 2017 | 31 | 43 |
| 2018 | 39 | 42 |
| 2019 | 27 | 33 |
| 2020 | 27 | 47 |
| 2021 | 23 | 59 |
| 2022 | 21 | 50 |
| 2023 | 30 | 63 |
| 2024 | 35 | 70 |
| 2025 | 27 | 72 |
| 2026 | 17 | 51 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Therapeutic methods for preventing tumor metastasis and tumor recurrence8 Sep 2026US 12,728,104 B2Lunella Biotech, Inc.
- Cleavable conjugates of catechol compounds and water-soluble polymers and methods of treatment using the same25 Aug 2026US 12,714,704 B2Serina Therapeutics (AL), Inc.
- Use of cannabidiol in the treatment of seizures associated with rare epilepsy syndromes related to structural abnormalities of the brain18 Aug 2026US 12,708,632 B2Jazz Pharmaceuticals Research UK Limited
- Formulations of psilocybin and psilocin compounds as serotonin agonists in combination with 3,4 methylenedioxymethamphetamine (MDMA)18 Aug 2026US 12,708,635 B2Altrartis Therapeutics Inc.
- Multifunctional cytoprotectant for treatment of pathogenic processes mediated by oxidative stress and toxic electrophiles4 Aug 2026US 12,697,310 B2Montefiore Medical Center
- Conformationally restricted phenethylamine analogs8 Oct 2026US 2026/0308109 A1
- Compositions and method for management of pain and allergy24 Sep 2026US 2026/0284003 A1
- Targeting the igf-1 pathway to extend organ lifespan24 Sep 2026US 2026/0284149 A1The Regents of the University of Michigan
- Methylophiopogonone a derivative, and preparation and use thereof24 Sep 2026US 2026/0285849 A1Institute of Materia Medica, Chinese Academy of Medical Sciences
- Drug combination for treating obesity17 Sep 2026US 2026/0272890 A1The Curators of the University of Missouri
Most cited
By later US patents
- Styryl compounds which inhibit EGF receptor protein tyrosine kinase181US 5,217,999 AYissum Research Development Company of the Hebrew University of Jerusalem · 1993
- Compositions and methods for treating surgical adhesions160US 6,689,803 B2Angiotech Pharmaceuticals, Inc. · 2004
- Bridged bicyclic aromatic compounds and their use in modulating gene expression of retinoid receptors129US 5,466,861 ALa Jolla Cancer Research Foundation · 1995
- Use of sulfamate derivatives for treating impulse control disorders114US 6,323,236 B2University of Cincinnati · 2001
- IL-8 receptor antagonists92US 5,886,044 ASmithKline Beecham Corporation · 1999